Sunesis Pharmaceuticals, Inc. (SNSS) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Willie Quinn - Chief Financial Officer & Senior Vice President, Corporate Development Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer Deepali Suri - Vice President, Clinical Operations Conference Call Participants Jim Birchenough - Wells Fargo Securities Hartaj Singh - Oppenheimer Kenneth Atkins - Cowen and Company Operator Welcome to the Sunesis Pharmaceu ...